EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22
De Weer, An × Speleman, Frank Cauwelier, Barbara Van Roy, Nadine Yigit, Nurten Verhasselt, Bruno De Moerloose, Barbara Benoit, Yves Noens, Lucien Selleslag, Dominik Lippert, Eric Struski, Stephanie Bastard, Christian De Paepe, Anne Vandenberghe, Peter Hagemeijer-Hausman, Anne Dastugue, Nicole Poppe, Bruce #
Il Pensiero Scientifico
Haematologica vol:93 issue:12 pages:1903-1907
Chromosomal translocations involving the EVI1 locus are a recurrent finding in myeloid leukemia and are associated with poor prognosis. In this study, we performed a detailed molecular characterization of the recurrent translocation t(3;17)(q26;q22) in 13 hematologic malignancies. The EVI1 gene locus was rearranged in all 13 patients and was associated with EVI1 overexpression. In 9 out of 13 patients, the 17q breakpoints clustered in a 250 kb region on band 17q22 encompassing the MSI2 (musashi homologue 2) gene. Expression analyses failed to demonstrate ectopic MSI2 expression or the presence of an MSI2/EVI1 fusion gene. In conclusion, we show for the first time that the t(3;17) is indeed a recurrent chromosomal aberration in myeloid malignancies. In keeping with findings in other recurrent 3q26 rearrangements, overexpression of the EVI1 gene appears to be the major contributor to leukemogenesis in patients with a t(3;17).